The impact of chemotherapy-naïve open radical cystectomy delay and perioperative transfusion on the recurrence-free survival: A perioperative parameters-based nomogram
Ahmed M. Harraz, Ahmed Elkarta, Mohamed H. Zahran, Ahmed Mosbah, Atallah A. Shaaban, Hassan Abol-Enein
{"title":"The impact of chemotherapy-naïve open radical cystectomy delay and perioperative transfusion on the recurrence-free survival: A perioperative parameters-based nomogram","authors":"Ahmed M. Harraz, Ahmed Elkarta, Mohamed H. Zahran, Ahmed Mosbah, Atallah A. Shaaban, Hassan Abol-Enein","doi":"10.1016/j.ajur.2022.09.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To develop and internally validate a nomogram to predict recurrence-free survival (RFS) including the time to radical cystectomy (RC) and perioperative blood transfusion (PBT) as potential predictors.</p></div><div><h3>Methods</h3><p>Patients who underwent open RC and ileal conduit between January 1996 to December 2016 were split into developing (<em>n</em>=948) and validating (<em>n</em>=237) cohorts. The time to radical cystectomy (TTC) was defined as the interval between the onset of symptoms and RC. The regression coefficients of the independent predictors obtained by Cox regression were used to construct the nomogram. Discrimination, validation, and clinical usefulness in the validation cohort were assessed by the area under the curve, the calibration plot, and decision curve analysis.</p></div><div><h3>Results</h3><p>In the developing dataset, the 1-, 5-, and 10-year RFS were 83.0%, 47.2%, and 44.4%, respectively. On multivariate analysis, independent predictors were TTC (hazards ratio [HR] 1.07, 95% confidence interval [CI] 1.05–1.08, <em>p</em><0.001), PBT (one unit: HR 1.40, 95% CI 1.03–1.90, <em>p</em>=0.03; two or more units: HR 1.72, 95% CI 1.29–2.29, <em>p</em><0.001), bilateral hydronephrosis (HR 1.54, 95% CI 1.21–1.97, <em>p</em><0.001), squamous cell carcinoma (HR 0.60, 95% CI 0.45–0.81, <em>p</em>=0.001), pT3-T4 (HR 1.77, 95% CI 1.41–2.22, <em>p</em><0.001), lymph node status (HR 1.53, 95% CI 1.21–1.95, <em>p</em><0.001), and lymphovascular invasion (HR 1.28, 95% CI 1.01–1.62, <em>p</em>=0.044). The areas under the curve in the validation dataset were 79.3%, 69.6%, and 76.2%, for 1-, 5-, and 10-year RFS, respectively. Calibration plots showed considerable correspondence between predicted and actual survival probabilities. The decision curve analysis revealed a better net benefit of the nomogram.</p></div><div><h3>Conclusion</h3><p>A nomogram with good discrimination, validation, and clinical utility was constructed utilizing TTC and PBT in addition to standard pathological criteria.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 2","pages":"Pages 294-303"},"PeriodicalIF":2.4000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214388222001321/pdfft?md5=462c9f1decf5dac275c950804f3342c2&pid=1-s2.0-S2214388222001321-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214388222001321","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To develop and internally validate a nomogram to predict recurrence-free survival (RFS) including the time to radical cystectomy (RC) and perioperative blood transfusion (PBT) as potential predictors.
Methods
Patients who underwent open RC and ileal conduit between January 1996 to December 2016 were split into developing (n=948) and validating (n=237) cohorts. The time to radical cystectomy (TTC) was defined as the interval between the onset of symptoms and RC. The regression coefficients of the independent predictors obtained by Cox regression were used to construct the nomogram. Discrimination, validation, and clinical usefulness in the validation cohort were assessed by the area under the curve, the calibration plot, and decision curve analysis.
Results
In the developing dataset, the 1-, 5-, and 10-year RFS were 83.0%, 47.2%, and 44.4%, respectively. On multivariate analysis, independent predictors were TTC (hazards ratio [HR] 1.07, 95% confidence interval [CI] 1.05–1.08, p<0.001), PBT (one unit: HR 1.40, 95% CI 1.03–1.90, p=0.03; two or more units: HR 1.72, 95% CI 1.29–2.29, p<0.001), bilateral hydronephrosis (HR 1.54, 95% CI 1.21–1.97, p<0.001), squamous cell carcinoma (HR 0.60, 95% CI 0.45–0.81, p=0.001), pT3-T4 (HR 1.77, 95% CI 1.41–2.22, p<0.001), lymph node status (HR 1.53, 95% CI 1.21–1.95, p<0.001), and lymphovascular invasion (HR 1.28, 95% CI 1.01–1.62, p=0.044). The areas under the curve in the validation dataset were 79.3%, 69.6%, and 76.2%, for 1-, 5-, and 10-year RFS, respectively. Calibration plots showed considerable correspondence between predicted and actual survival probabilities. The decision curve analysis revealed a better net benefit of the nomogram.
Conclusion
A nomogram with good discrimination, validation, and clinical utility was constructed utilizing TTC and PBT in addition to standard pathological criteria.
期刊介绍:
Asian Journal of Urology (AJUR), launched in October 2014, is an international peer-reviewed Open Access journal jointly founded by Shanghai Association for Science and Technology (SAST) and Second Military Medical University (SMMU). AJUR aims to build a communication platform for international researchers to effectively share scholarly achievements. It focuses on all specialties of urology both scientifically and clinically, with article types widely covering editorials, opinions, perspectives, reviews and mini-reviews, original articles, cases reports, rapid communications, and letters, etc. Fields of particular interest to the journal including, but not limited to: • Surgical oncology • Endourology • Calculi • Female urology • Erectile dysfunction • Infertility • Pediatric urology • Renal transplantation • Reconstructive surgery • Radiology • Pathology • Neurourology.